PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 122 filers reported holding PMV PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,000 | +60.0% | 6,486 | +61.2% | 0.00% | – |
| Q2 2023 | $25,000 | +150.0% | 4,024 | +94.7% | 0.00% | – |
| Q1 2023 | $10,000 | -76.2% | 2,067 | -57.3% | 0.00% | – |
| Q4 2022 | $42,000 | +740.0% | 4,837 | +977.3% | 0.00% | – |
| Q3 2022 | $5,000 | +66.7% | 449 | +116.9% | 0.00% | – |
| Q2 2022 | $3,000 | -91.2% | 207 | -87.2% | 0.00% | – |
| Q1 2022 | $34,000 | -75.5% | 1,611 | -73.2% | 0.00% | – |
| Q4 2021 | $139,000 | +104.4% | 6,006 | +163.3% | 0.00% | – |
| Q3 2021 | $68,000 | +9.7% | 2,281 | +24.8% | 0.00% | – |
| Q2 2021 | $62,000 | +72.2% | 1,828 | +67.2% | 0.00% | – |
| Q1 2021 | $36,000 | +38.5% | 1,093 | +163.4% | 0.00% | – |
| Q4 2020 | $26,000 | – | 415 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 3,234,911 | $74,726,000 | 44.17% |
| Euclidean Capital LLC | 2,336,909 | $53,983,000 | 30.69% |
| OUP Management Co., LLC | 989,232 | $22,851,000 | 10.30% |
| Nextech Invest Ltd. | 1,385,807 | $32,012,000 | 8.43% |
| Boxer Capital, LLC | 2,838,236 | $65,563,000 | 2.55% |
| PERSONAL CFO SOLUTIONS, LLC | 550,342 | $12,713,000 | 2.38% |
| Orbimed Advisors | 7,330,423 | $169,333,000 | 2.18% |
| Asymmetry Capital Management, L.P. | 97,680 | $2,256,000 | 1.20% |
| RTW INVESTMENTS, LP | 2,980,960 | $68,860,000 | 1.01% |
| HighVista Strategies LLC | 39,777 | $919,000 | 0.73% |